Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- a...
Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way
About this item
Full title
Author / Creator
Publisher
Dordrecht: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Dordrecht: Springer
Subjects
More information
Scope and Contents
Contents
Celastrol, a novel HSP90 inhibitor, has recently attracted much attention due to its potential in multiple applications, such as anti-inflammation use, degenerative neuron disease relief, and tumor management. At present, the studies in celastrol's effects on HSP90's clients have focused on the kinase sub-population, while another key sub-populatio...
Alternative Titles
Full title
Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3024068
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3024068
Other Identifiers
ISSN
1355-8145
E-ISSN
1466-1268
DOI
10.1007/s12192-010-0202-1
